Bayer Announces CFO Transition, 2026 Financial Outlook, and Roundup Litigation Update
Bayer Aktiengesellschaft announced the appointment of Judith Hartmann as CFO, effective June 1, 2026, and provided an outlook for 2026, which includes increased net financial debt and negative free cash flow due to litigation costs. The company also updated shareholders on the Roundup litigation, with a class settlement receiving preliminary approval and a U.S. Supreme Court hearing expected.
Topics: CFO Transition Corporate Governance Executive Contracts Financial Outlook Litigation Update